|
DE2856393C2
(de)
*
|
1978-12-27 |
1983-04-28 |
Merz + Co GmbH & Co, 6000 Frankfurt |
Arzneimittel zur Behandlung von Morbus Parkinson
|
|
US5506231A
(en)
*
|
1989-03-31 |
1996-04-09 |
The Children's Medical Center Corporation |
Treatment of aids dementia, myelopathy and blindness
|
|
US5334618A
(en)
*
|
1991-04-04 |
1994-08-02 |
The Children's Medical Center Corporation |
Method of preventing NMDA receptor-mediated neuronal damage
|
|
US5614560A
(en)
*
|
1991-04-04 |
1997-03-25 |
Children's Medical Center Corporation |
Method of preventing NMDA receptor-mediated neuronal damage
|
|
US5455279A
(en)
*
|
1991-04-19 |
1995-10-03 |
The Children's Medical Center Corporation |
Regimen method of mediating neuronal damage using nitroglycerine
|
|
WO1992017168A1
(en)
*
|
1991-04-04 |
1992-10-15 |
The Children's Medical Center Corporation |
Method of preventing nmda receptor-mediated neuronal damage
|
|
DE4225730C2
(de)
*
|
1992-08-04 |
2003-04-30 |
Merz Pharma Gmbh & Co Kgaa |
Verfahren zur Herstellung von festen Arzneiformkörpern mit protrahierter 2-Stufen-Freisetzung
|
|
US6057373A
(en)
*
|
1997-05-22 |
2000-05-02 |
Synchroneuron, Llc |
Methods of treating tardive dyskinesia and other movement disorders using NMDA receptor antagonists
|
|
US5866585A
(en)
*
|
1997-05-22 |
1999-02-02 |
Synchroneuron, Llc |
Methods of treating tardive dyskinesia using NMDA receptor antagonists
|
|
US5952389A
(en)
*
|
1998-01-13 |
1999-09-14 |
Synchroneuron |
Methods of treating tardive dyskinesia and other movement disorders
|
|
US6294583B1
(en)
*
|
1998-01-13 |
2001-09-25 |
Synchroneuron, Llc |
Methods of treating tardive dyskinesia and other movement disorders
|
|
US6444702B1
(en)
|
2000-02-22 |
2002-09-03 |
Neuromolecular, Inc. |
Aminoadamantane derivatives as therapeutic agents
|
|
AU2002329799B2
(en)
*
|
2001-08-20 |
2007-03-15 |
Maiken Nedergaard |
Treatment of glial tumors with glutamate antagonists
|
|
EP1298581A1
(fr)
*
|
2001-09-27 |
2003-04-02 |
C.S.E.M. Centre Suisse D'electronique Et De Microtechnique Sa |
Procédé et dispositif pour calculer les valeurs des neurones d'un réseau neuronal
|
|
WO2004037234A2
(en)
|
2002-10-24 |
2004-05-06 |
Merz Pharma Gmbh & Co. Kgaa |
Combination therapy using 1-aminocyclohexane derivatives and acetylcholinesterase inhibitors
|
|
RU2246482C2
(ru)
*
|
2002-12-25 |
2005-02-20 |
ООО "Циклан" |
Способ получения гидрохлорида 1-амино-3,5-диметиладамантана
|
|
JP2007500238A
(ja)
*
|
2003-05-27 |
2007-01-11 |
フォーレスト ラボラトリーズ， インコーポレイテッド |
うつ病及びその他の気分障害のために、ｎｍｄａ受容体アンタゴニストと選択的セロトニン再取り込み阻害薬の併用
|
|
CN1240668C
(zh)
*
|
2003-09-10 |
2006-02-08 |
上海医药工业研究院 |
一种新的盐酸美金刚制备方法
|
|
DE602004017207D1
(de)
*
|
2003-10-22 |
2008-11-27 |
Merz Pharma Gmbh & Co Kgaa |
Verwendung von 1-aminocyclohexan-derivaten zur modifizierung der abscheidung von fibrillogenen as peptiden in amyloidpathien
|
|
AR046314A1
(es)
|
2003-11-05 |
2005-11-30 |
Merz Pharma Gmbh & Co Kgaa |
Composiciones que comprenden ciclohexilaminas y aminoadamantanos
|
|
WO2005069742A2
(en)
*
|
2003-12-10 |
2005-08-04 |
Sun Pharmaceutical Industries Limited |
Crystal form ii of memantine hydrochloride
|
|
PT1703902E
(pt)
*
|
2004-01-05 |
2010-11-17 |
Merz Pharma Gmbh & Co Kgaa |
Memantina para o tratamento da doença de alzheimer ligeira e ligeira a moderada
|
|
CN100363329C
(zh)
*
|
2004-01-09 |
2008-01-23 |
南京大学 |
合成美金刚胺盐酸盐的方法
|
|
US7456224B2
(en)
*
|
2004-04-05 |
2008-11-25 |
Forest Laboratories Holdings, Ltd. |
Method for treating autism
|
|
US8039009B2
(en)
*
|
2004-06-17 |
2011-10-18 |
Forest Laboratories Holdings Limited |
Modified release formulations of memantine oral dosage forms
|
|
US20060002999A1
(en)
|
2004-06-17 |
2006-01-05 |
Forest Laboratories, Inc. |
Immediate release formulations of 1-aminocyclohexane compounds, memantine and neramexane
|
|
BRPI0512263A
(pt)
|
2004-06-17 |
2008-02-26 |
Merz Pharma Gmbh & Co Kgaa |
formulações de liberação imediata de formas de dosagem oral de memantina
|
|
TW200616608A
(en)
*
|
2004-07-09 |
2006-06-01 |
Forest Laboratories |
Memantine as adjunctive treatment to atypical antipsychotics in schizophrenia patients
|
|
KR20070046185A
(ko)
*
|
2004-09-23 |
2007-05-02 |
메르츠 파마 게엠베하 운트 코. 카가아 |
소아 행동장애의 치료를 위한 메만틴
|
|
US20060205822A1
(en)
*
|
2004-12-22 |
2006-09-14 |
Forest Laboratories, Inc. |
1-Aminocyclohexane derivatives for the treatment of multiple sclerosis, emotional lability and pseudobulbar affect
|
|
EP1836157B1
(en)
*
|
2005-01-11 |
2009-10-07 |
Teva Pharmaceutical Fine Chemicals S.R.L. |
Process for the preparation of 1-amino-3,5-dimethyladamantane hydrochloride
|
|
ITMI20050833A1
(it)
*
|
2005-05-10 |
2006-11-11 |
A M S A S P A Anonima Materie Sintetiche Affini |
Nuovo procedimento per la sintesi di aminoadamantani
|
|
WO2006138227A1
(en)
*
|
2005-06-16 |
2006-12-28 |
Forest Laboratories, Inc. |
Modified and immediate release memantine bead formulation
|
|
BRPI0613943B1
(pt)
|
2005-07-27 |
2021-06-22 |
Otsuka America Pharmaceutical, Inc |
Composto, composição farmacêutica o compreendendo, usos de um composto e de uma composição farmacêutica, bem como composição neurobiologicamente ativa
|
|
US20070099947A1
(en)
*
|
2005-11-03 |
2007-05-03 |
Alkermes, Inc. |
Methods and compositions for the treatment of brain reward system disorders by combination therapy
|
|
PL1820792T3
(pl)
*
|
2006-02-21 |
2012-06-29 |
Hexal Ag |
Sposób otrzymywania adamantanoamin
|
|
ES2310504T1
(es)
*
|
2006-03-27 |
2009-01-16 |
Teva Pharmaceutical Fine Chemicals S.R.L. |
Procedimiento para la preparacion de clorhidrato de memantina sustancialmente libre de impurezas.
|
|
TWI399376B
(zh)
|
2006-08-04 |
2013-06-21 |
Merz Pharma Gmbh & Co Kgaa |
經取代之吡唑並嘧啶類，製備彼等之方法及彼等作為藥物之用途
|
|
EP1908748A1
(en)
*
|
2006-10-05 |
2008-04-09 |
Krka |
Process for the preparation of memantine and its hydrochloric acid salt form
|
|
US20080108643A1
(en)
*
|
2006-11-03 |
2008-05-08 |
Forest Laboratories Holdings Limited |
Method for treating autism
|
|
CA2673481A1
(en)
|
2006-12-19 |
2008-06-26 |
University Of Virginia Patent Foundation |
Combined effects of topiramate and ondansetron on alcohol consumption
|
|
WO2008105442A1
(ja)
|
2007-02-28 |
2008-09-04 |
Asahi Kasei Pharma Corporation |
スルホンアミド誘導体
|
|
WO2008153937A2
(en)
|
2007-06-06 |
2008-12-18 |
Dov Pharmaceutical, Inc. |
Novel 1- heteroaryl-3-azabicyclo[3.1.0]hexanes, methods for their preparation and their use as medicaments
|
|
US9133159B2
(en)
|
2007-06-06 |
2015-09-15 |
Neurovance, Inc. |
1-heteroaryl-3-azabicyclo[3.1.0]hexanes, methods for their preparation and their use as medicaments
|
|
GB0713930D0
(en)
|
2007-07-18 |
2007-08-29 |
Generics Uk Ltd |
Novel assay methods
|
|
EP2085398A1
(en)
|
2008-02-01 |
2009-08-05 |
Merz Pharma GmbH & Co. KGaA |
Pyrazolopyrimidines, a process for their preparation and their use as medicine
|
|
EP2090576A1
(en)
|
2008-02-01 |
2009-08-19 |
Merz Pharma GmbH & Co.KGaA |
6-halo-pyrazolo[1,5-a]pyridines, a process for their preparation and their use as metabotropic glutamate receptor (mGluR) modulators
|
|
WO2009151498A2
(en)
*
|
2008-03-28 |
2009-12-17 |
Forest Laboratories Holdings Limited |
Memantine formulations
|
|
US20110034565A1
(en)
|
2008-04-18 |
2011-02-10 |
University College Dublin, National University Of Ireland, Dublin |
Psycho-pharmaceuticals
|
|
EP2111858A1
(en)
|
2008-04-25 |
2009-10-28 |
EPFL Ecole Polytechnique Fédérale de Lausanne |
Novel treatment for alzheimer's disease
|
|
US20090275597A1
(en)
*
|
2008-05-02 |
2009-11-05 |
Forest Laboratories Holdings Limited |
Methods of treating cns disorders
|
|
EP2138173A1
(en)
|
2008-06-26 |
2009-12-30 |
Merz Pharma GmbH & Co.KGaA |
Pharmaceutical compositions comprising aminoadamantane derivatives
|
|
JP5195256B2
(ja)
*
|
2008-10-10 |
2013-05-08 |
東ソー株式会社 |
アミノアダマンタン誘導体の製造方法
|
|
HRP20090186A2
(hr)
|
2009-03-31 |
2010-10-31 |
Institut Ruđer Bošković |
Adamantanski bisureidni derivati, metoda priprave i primjena u detekciji aniona
|
|
WO2010112221A1
(en)
|
2009-04-03 |
2010-10-07 |
Synthon B.V. |
Pharmaceutical compositions comprising memantine
|
|
CN102070463A
(zh)
*
|
2009-06-11 |
2011-05-25 |
辽宁利锋科技开发有限公司 |
具有金刚烷结构药物美金刚胺及其衍生物和类似物抗肿瘤新适应症的应用
|
|
TW201116532A
(en)
|
2009-08-05 |
2011-05-16 |
Merz Pharma Gmbh & Co Kgaa |
Metabotropic glutamate receptor modulators
|
|
EP2506709B2
(en)
|
2009-12-02 |
2019-10-09 |
Adamas Pharmaceuticals, Inc. |
Amantadine compositions and methods of use
|
|
US20110251239A1
(en)
|
2010-04-07 |
2011-10-13 |
Eisai Inc. |
Combination therapy for the treatment of dementia
|
|
AR083475A1
(es)
|
2010-10-18 |
2013-02-27 |
Merz Pharma Gmbh & Co Kgaa |
Moduladores de receptores de glutamato metabotropicos
|
|
KR20130132829A
(ko)
|
2010-10-29 |
2013-12-05 |
메르츠 파마 게엠베하 운트 코. 카가아 |
인돌 유도체 및 이의 제조 방법
|
|
WO2012068161A1
(en)
|
2010-11-15 |
2012-05-24 |
Agenebio, Inc. |
Pyridazine derivatives, compositions and methods for treating cognitive impairment
|
|
WO2012085166A1
(en)
|
2010-12-22 |
2012-06-28 |
Merz Pharma Gmbh & Co. Kgaa |
Metabotropic glutamate receptor modulators
|
|
AR084515A1
(es)
|
2010-12-22 |
2013-05-22 |
Merz Pharma Gmbh & Co Kgaa |
Derivados heterociclicos nitrogenados, composiciones farmaceuticas que los contienen y uso de los mismos en el tratamiento de enfermedades asociadas al sistema nervioso central tales como parkinson y alzheimer, entre otras
|
|
CN102241678B
(zh)
|
2011-04-26 |
2014-10-29 |
辽宁利锋科技开发有限公司 |
含有脂环结构化合物的抗肿瘤作用与应用
|
|
WO2012152854A1
(en)
|
2011-05-12 |
2012-11-15 |
Merz Pharma Gmbh & Co. Kgaa |
Metabotropic glutamate receptor modulators
|
|
WO2012172093A1
(en)
|
2011-06-17 |
2012-12-20 |
Merz Pharma Gmbh & Co. Kgaa |
Dihydroindolizine derivate as metabotropic glutamate receptor modulators
|
|
US20140206740A1
(en)
|
2011-07-30 |
2014-07-24 |
Neurovance, Inc. |
Use Of (1R,5S)-(+)-(Napthalen-2-yl)-3-Azabicyclo[3.1.0]Hexane In The Treatment Of Conditions Affected By Monoamine Neurotransmitters
|
|
CN103288650B
(zh)
*
|
2012-02-28 |
2015-09-30 |
广州白云山制药股份有限公司广州白云山制药总厂 |
一种盐酸1-氨基-3,5-二甲基金刚烷的制备方法
|
|
EP2650284A1
(en)
|
2012-04-10 |
2013-10-16 |
Merz Pharma GmbH & Co. KGaA |
Heterocyclic derivatives as metabotropic glutamate receptor modulators
|
|
RU2488388C1
(ru)
|
2012-05-24 |
2013-07-27 |
Ооо "Валента Интеллект" |
Фармацевтическая композиция для профилактики и лечения психических, поведенческих, когнитивных расстройств
|
|
US10154971B2
(en)
|
2013-06-17 |
2018-12-18 |
Adamas Pharma, Llc |
Methods of administering amantadine
|
|
US9566264B2
(en)
|
2013-07-01 |
2017-02-14 |
Euthymics Bioscience, Inc. |
Combinations and methods
|
|
EP4032889A1
(en)
|
2013-12-20 |
2022-07-27 |
Agenebio, Inc. |
Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment
|
|
CA2938671A1
(en)
|
2014-02-04 |
2015-08-13 |
Forest Laboratories Holdings Limited |
Donepezil compositions and method of treating alzheimer's disease
|
|
EP3310785B1
(en)
|
2015-06-19 |
2024-11-20 |
Agenebio, Inc. |
Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment
|
|
JP6354701B2
(ja)
*
|
2015-08-19 |
2018-07-11 |
大日本印刷株式会社 |
高純度メマンチン塩酸塩の製造法
|
|
CA3010183A1
(en)
|
2015-12-30 |
2017-07-06 |
Corium International, Inc. |
Systems and methods for long term transdermal administration
|
|
CA3028436A1
(en)
|
2016-06-23 |
2017-12-28 |
Corium International, Inc. |
Adhesive matrix with hydrophilic and hydrophobic domains and a therapeutic agent
|
|
KR20230109782A
(ko)
|
2016-07-27 |
2023-07-20 |
코리움, 엘엘씨 |
아민 약물의 나트륨 바이카보네이트 제자리 전환 구동된경피성 전달
|
|
CA3032103A1
(en)
|
2016-07-27 |
2018-02-01 |
Corium International, Inc. |
Memantine transdermal delivery systems
|
|
KR102424270B1
(ko)
|
2016-07-27 |
2022-07-25 |
코리움, 인크. |
경구 전달과 생물학적으로 동등한 약물동역학을 가진 경피 전달 시스템
|
|
US20180170941A1
(en)
|
2016-12-19 |
2018-06-21 |
Agenebio, Inc. |
Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment
|
|
US11505555B2
(en)
|
2016-12-19 |
2022-11-22 |
Agenebio, Inc. |
Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment
|
|
US10369187B2
(en)
|
2017-02-09 |
2019-08-06 |
Vanderbilt University |
Peptide regulators of JNK family kinases
|
|
JP2019094304A
(ja)
*
|
2017-11-27 |
2019-06-20 |
学校法人順天堂 |
オートファジー誘導剤
|
|
CA3086163A1
(en)
|
2017-12-20 |
2019-06-27 |
Corium, Inc. |
Transdermal adhesive composition comprising a volatile liquid therapeutic agent having low melting point
|
|
MX2020013927A
(es)
|
2018-06-19 |
2021-03-02 |
Agenebio Inc |
Derivados de benzodiazepina, composiciones y metodos para tratar el deterioro cognitivo.
|
|
EP3721857A1
(en)
*
|
2019-04-11 |
2020-10-14 |
Dentsply DeTrey GmbH |
Dental composition
|
|
WO2021232232A1
(zh)
*
|
2020-05-19 |
2021-11-25 |
山东泓瑞医药科技股份公司 |
一种金刚烷胺的制备方法
|
|
AU2023324882A1
(en)
|
2022-08-19 |
2025-03-20 |
Agenebio, Inc. |
Benzazepine derivatives, compositions, and methods for treating cognitive impairment
|